BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

17547

590006

AMRUTANJAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AMRUTAJAN HEALTH LTD performance

Today’s low

Today’s high

₹ 544.10 ₹ 709.00
₹ 694.30

52 week low

52 week high

₹ 559.95 ₹ 862.60
₹ 694.30

Open Price

₹ 684.35

Prev. Close

₹ 680.10

Volume (Shares)

222553.00

Total traded value

₹ 1545.18

Upper Circuit

₹ 816.10

Lower Circuit

₹ 544.10

info

AMRUTAJAN HEALTH LTD Share Price Update

As of the latest trading session, AMRUTAJAN HEALTH LTD share price is currently at ₹ 694.3, which is up by ₹ 14.20 from its previous closing. Today, the stock has fluctuated between ₹ 544.10 and ₹ 709.00. Over the past year, AMRUTAJAN HEALTH LTD has achieved a return of -0.62 %. In the last month alone, the return has been 7.88 %. Read More...

AMRUTAJAN HEALTH LTD fundamentals


  • Market cap (Cr)

    1,014.74

  • P/E Ratio (TTM)

    39.81

  • Beta

    0.76

  • Book Value / share

    103.00

  • Return on equity

    15.53%

  • EPS (TTM)

    17.06

  • Dividend yield

    0.68%

  • Net profit/quarter (Cr)

    19.25

info icon alternate text
  • Market cap (Cr)

    1,022.92

  • P/E Ratio (TTM)

    39.81

  • Beta

    0.67

  • Book Value / share

    103.00

  • Return on equity

    15.53%

  • EPS (TTM)

    17.06

  • Dividend yield

    0.68%

  • Net profit/quarter (Cr)

    19.25

info icon alternate text

AMRUTAJAN HEALTH LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 122.75
Operating Expense 101.13
Net Profit 19.25
Net Profit Margin (%) 15.68
Earnings Per Share (EPS) 6.66
EBITDA 27.70
Effective Tax Rate (%) 25.93
Particulars SEP 2024 (Values in Cr)
Revenue 109.92
Operating Expense 98.03
Net Profit 11.80
Net Profit Margin (%) 10.73
Earnings Per Share (EPS) 4.08
EBITDA 17.65
Effective Tax Rate (%) 25.97
Particulars JUN 2024 (Values in Cr)
Revenue 83.74
Operating Expense 81.83
Net Profit 4.62
Net Profit Margin (%) 5.51
Earnings Per Share (EPS) 1.60
EBITDA 7.99
Effective Tax Rate (%) 27.24
Particulars MAR 2024 (Values in Cr)
Revenue 127.06
Operating Expense 112.41
Net Profit 13.66
Net Profit Margin (%) 10.75
Earnings Per Share (EPS) 4.72
EBITDA 21.18
Effective Tax Rate (%) 30.35
Particulars DEC 2023 (Values in Cr)
Revenue 116.99
Operating Expense 97.05
Net Profit 17.45
Net Profit Margin (%) 14.91
Earnings Per Share (EPS) 6.05
EBITDA 25.34
Effective Tax Rate (%) 26.40
Particulars MAR 2024 (Values in Cr)
Revenue 421.23
Operating Expense 375.64
Net Profit 44.97
Net Profit Margin (%) 10.67
Earnings Per Share (EPS) 15.50
EBITDA 68.17
Effective Tax Rate (%) 27.39
Particulars MAR 2023 (Values in Cr)
Revenue 379.64
Operating Expense 340.53
Net Profit 39.83
Net Profit Margin (%) 10.49
Earnings Per Share (EPS) 13.65
EBITDA 58.94
Effective Tax Rate (%) 25.74
Particulars MAR 2022 (Values in Cr)
Revenue 405.84
Operating Expense 330.64
Net Profit 67.19
Net Profit Margin (%) 16.55
Earnings Per Share (EPS) 23.05
EBITDA 94.86
Effective Tax Rate (%) 25.82
Particulars MAR 2021 (Values in Cr)
Revenue 332.84
Operating Expense 262.26
Net Profit 61.19
Net Profit Margin (%) 18.38
Earnings Per Share (EPS) 20.94
EBITDA 86.07
Effective Tax Rate (%) 25.28
Particulars MAR 2020 (Values in Cr)
Revenue 261.48
Operating Expense 235.34
Net Profit 25.08
Net Profit Margin (%) 9.59
Earnings Per Share (EPS) 8.58
EBITDA 39.03
Effective Tax Rate (%) 27.19
Particulars MAR 2016 (Values in Cr)
Book Value / Share 74.40
ROE % 20.21
ROCE % 31.43
Total Debt to Total Equity 0.02
EBITDA Margin 18.63
Particulars MAR 2015 (Values in Cr)
Book Value / Share 64.97
ROE % 16.18
ROCE % 25.28
Total Debt to Total Equity 0.06
EBITDA Margin 16.05
Particulars MAR 2014 (Values in Cr)
Book Value / Share 61.06
ROE % 14.51
ROCE % 21.52
Total Debt to Total Equity 0.13
EBITDA Margin 16.64
Particulars MAR 2013 (Values in Cr)
Book Value / Share 56.29
ROE % 12.69
ROCE % 18.14
Total Debt to Total Equity 0.23
EBITDA Margin 14.95
Particulars MAR 2012 (Values in Cr)
Book Value / Share 264.62
ROE % 10.78
ROCE % 16.36
Total Debt to Total Equity 0.29
EBITDA Margin 14.94
Particulars MAR 2024 (Values in Cr)
Book Value / Share 99.78
ROE % 15.53
ROCE % 20.84
Total Debt to Total Equity 0.00
EBITDA Margin 16.20
Particulars MAR 2023 (Values in Cr)
Book Value / Share 99.47
ROE % 14.33
ROCE % 18.81
Total Debt to Total Equity 0.00
EBITDA Margin 15.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 90.70
ROE % 27.96
ROCE % 36.78
Total Debt to Total Equity 0.00
EBITDA Margin 23.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.75
ROE % 32.64
ROCE % 42.34
Total Debt to Total Equity 0.01
EBITDA Margin 25.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.54
ROE % 16.44
ROCE % 21.86
Total Debt to Total Equity 0.01
EBITDA Margin 14.97
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 48.24
Total Assets 140.43
Total Liabilities 140.43
Total Equity 108.74
Share Outstanding 14615315
Price to Book Ratio 5.06
Return on Assets (%) 14.65
Return on Capital (%) 18.5
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 37.88
Total Assets 123.90
Total Liabilities 123.90
Total Equity 94.95
Share Outstanding 14615315
Price to Book Ratio 6.67
Return on Assets (%) 12.02
Return on Capital (%) 15.29
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 35.20
Total Assets 120.26
Total Liabilities 120.26
Total Equity 89.23
Share Outstanding 14615315
Price to Book Ratio 1.89
Return on Assets (%) 10.34
Return on Capital (%) 12.8
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 14.90
Total Assets 124.15
Total Liabilities 124.15
Total Equity 82.26
Share Outstanding 14615315
Price to Book Ratio 1.93
Return on Assets (%) 8.14
Return on Capital (%) 10.4
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 15.23
Total Assets 124.20
Total Liabilities 124.20
Total Equity 77.26
Share Outstanding 2923063
Price to Book Ratio 2.77
Return on Assets (%) 7.75
Return on Capital (%) 9.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 26.60
Total Assets 366.87
Total Liabilities 366.87
Total Equity 288.48
Share Outstanding 28910630
Price to Book Ratio 6.20
Return on Assets (%) 12.25
Return on Capital (%) 15.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.31
Total Assets 362.09
Total Liabilities 362.09
Total Equity 290.77
Share Outstanding 29230630
Price to Book Ratio 5.78
Return on Assets (%) 11.00
Return on Capital (%) 13.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 87.75
Total Assets 349.86
Total Liabilities 349.86
Total Equity 265.12
Share Outstanding 29230630
Price to Book Ratio 8.75
Return on Assets (%) 19.20
Return on Capital (%) 25.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 139.31
Total Assets 274.27
Total Liabilities 274.27
Total Equity 215.56
Share Outstanding 29230630
Price to Book Ratio 7.71
Return on Assets (%) 22.31
Return on Capital (%) 28.39
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 36.32
Total Assets 205.34
Total Liabilities 205.34
Total Equity 159.42
Share Outstanding 29230630
Price to Book Ratio 6.05
Return on Assets (%) 12.21
Return on Capital (%) 15.73
Particulars MAR 2016 (Values in Cr)
Net Income 32.68
Cash from Operations 32.18
Cash from Investing 4.16
Cash from Financing -13.10
Net change in Cash 11.75
Free Cash Flow 34.38
Particulars MAR 2015 (Values in Cr)
Net Income 24.14
Cash from Operations 27.69
Cash from Investing -4.89
Cash from Financing -11.92
Net change in Cash 1.49
Free Cash Flow 33.49
Particulars MAR 2014 (Values in Cr)
Net Income 19.38
Cash from Operations 24.80
Cash from Investing 16.49
Cash from Financing -13.91
Net change in Cash 20.02
Free Cash Flow 25.94
Particulars MAR 2013 (Values in Cr)
Net Income 15.47
Cash from Operations 14.14
Cash from Investing 7.73
Cash from Financing -14.26
Net change in Cash 2.08
Free Cash Flow 15.48
Particulars MAR 2012 (Values in Cr)
Net Income 16.11
Cash from Operations 8.72
Cash from Investing 14.49
Cash from Financing -27.30
Net change in Cash -9.18
Free Cash Flow 21.48
Particulars MAR 2024 (Values in Cr)
Net Income 61.94
Cash from Operations 44.40
Cash from Investing 19.16
Cash from Financing -48.26
Net change in Cash -1.19
Free Cash Flow 51.12
Particulars MAR 2023 (Values in Cr)
Net Income 53.64
Cash from Operations 36.24
Cash from Investing -2.47
Cash from Financing -14.98
Net change in Cash 2.71
Free Cash Flow 45.17
Particulars MAR 2022 (Values in Cr)
Net Income 90.57
Cash from Operations 76.38
Cash from Investing -36.21
Cash from Financing -16.70
Net change in Cash -0.71
Free Cash Flow 99.85
Particulars MAR 2021 (Values in Cr)
Net Income 81.90
Cash from Operations 109.56
Cash from Investing -87.76
Cash from Financing -7.42
Net change in Cash -4.31
Free Cash Flow 109.56
Particulars MAR 2020 (Values in Cr)
Net Income 34.45
Cash from Operations 29.32
Cash from Investing -13.85
Cash from Financing -11.68
Net change in Cash -7.36
Free Cash Flow 29.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95
ABBOTT INDIA LIMITED 29876.95 47.58 18.03 63488.52 25260.20 / 31900.00

AMRUTAJAN HEALTH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
694.30 2.08 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 670.40
  • 26 Days 652.30
  • 10 Days 666.30
  • 50 Days 649.00
  • 12 Days 664.30
  • 100 Days 664.20
  • 20 Days 656.50
  • 200 Days 682.80
677.70 PIVOT

First Support

667.95

First Resistance

689.85

Second Support

655.80

Second Resistance

699.60

Third Support

646.05

Third Resistance

711.75

RSI

61.75

ADX

24.38

MACD

13.44

Williams % R

-20.91

Commodity Channel Index (CCI)

-31.28

Date

2025-04-30

Week

22550.00

Same Day

102789.00

Month

14526.00

1 Year

0.76

3 Year

0.59

Over 1 Month

7.88%

down

Over 1 Year

-0.62%

down

Over 3 Months

4.24%

down

Over 3 Years

-8.24%

down

Over 6 Months

-5.96%

down

Over 5 Years

12.18%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

AMRUTAJAN HEALTH LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
39.77%
Promoter Holdings
46.51%
FII
2.29%
DII
11.4%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Goodhealth Holdings Private Limited 5825803.0 (20.15%) Shareholding of Promoter and Promoter Group
Sambhuprasad Sivalenka 2990730.0 (10.34%) Shareholding of Promoter and Promoter Group
Dsp Small Cap Fund 1466269.0 (5.07%) Public Shareholding
Ramaa Prabhakar Arikirevula 1371530.0 (4.74%) Shareholding of Promoter and Promoter Group
Sambhu Prasad Sivalenka 1040171.0 (3.6%) Shareholding of Promoter and Promoter Group
Ramaa P Arikirevula 872535.0 (3.02%) Shareholding of Promoter and Promoter Group
Carnelian Bharat Amritkaal Fund 864054.0 (2.99%) Public Shareholding
Ramalingam Ganti 730640.0 (2.53%) Shareholding of Promoter and Promoter Group
Icici Prudential Fmcg Fund 713715.0 (2.47%) Public Shareholding
Amulya Kamakshi Priya Arikirevula 616781.0 (2.13%) Shareholding of Promoter and Promoter Group
Dipak Kanayalal Shah 314836.0 (1.09%) Public Shareholding

News

Left Arrow
Right Arrow

AMRUTAJAN HEALTH LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Feb 2024 1.0 Interim 2 20 Feb 2024 Equity shares
23 Nov 2023 1.0 Interim 1 23 Nov 2023 Equity shares
14 Sep 2023 2.6 Final 14 Sep 2023 Equity shares
24 Feb 2023 1.0 Interim 2 24 Feb 2023 Equity shares
14 Nov 2022 1.0 Interim 1 15 Nov 2022 Equity shares
14 Sep 2022 2.6 Final 16 Sep 2022 Equity shares
18 Feb 2022 1.0 Interim 2 21 Feb 2022 Equity shares
16 Nov 2021 1.0 Interim 1 17 Nov 2021 Equity shares
15 Sep 2021 2.6 Final 16 Sep 2021 Equity shares
17 Feb 2021 0.8 Interim 2 19 Feb 2021 Equity shares
19 Nov 2020 0.8 Interim 1 20 Nov 2020 Equity shares
18 Feb 2020 1.55 Interim 2 21 Feb 2020 Equity shares
15 Nov 2019 0.55 Interim 1 18 Nov 2019 Equity shares
17 Sep 2019 1.05 Final 19 Sep 2019 Equity shares
20 Feb 2019 0.55 Interim 2 21 Feb 2019 Equity shares
12 Nov 2018 0.55 Interim 1 13 Nov 2018 Equity shares
07 Sep 2018 0.85 Final 11 Sep 2018 Equity shares
22 Feb 2018 1.1 Interim 2 23 Feb 2018 Equity shares
16 Nov 2017 1.1 Interim 1 17 Nov 2017 Equity shares
13 Sep 2017 1.65 Final 14 Sep 2017 Equity shares
16 Feb 2017 1.1 Interim 2 17 Feb 2017 Equity shares
17 Nov 2016 1.1 Interim 1 18 Nov 2016 Equity shares
18 Mar 2016 2.65 Interim 2 21 Mar 2016 Equity shares
17 Feb 2016 1.2 Interim 19 Feb 2016 Equity shares
10 Sep 2015 2.4 Final 12 Sep 2015 Equity shares
13 Feb 2015 1.1 Interim 17 Feb 2015 Equity shares
17 Sep 2014 2.2 Final 19 Sep 2014 Equity shares
17 Feb 2014 1.0 Interim 19 Feb 2014 Equity shares
02 Aug 2013 2.0 Final 06 Aug 2013 Equity shares
21 Feb 2013 1.0 Interim 22 Feb 2013 Equity shares
20 Sep 2012 10.0 Final 24 Sep 2012 Equity shares
23 Feb 2012 5.0 Interim 24 Feb 2012 Equity shares
12 Sep 2011 10.0 Final 14 Sep 2011 Equity shares
21 Feb 2011 5.0 Interim 22 Feb 2011 Equity shares
13 Aug 2010 10.0 Final 17 Aug 2010 Equity shares
09 Feb 2010 5.0 Interim 10 Feb 2010 Equity shares
16 Sep 2009 12.0 Final 18 Sep 2009 Equity shares
04 Feb 2009 5.0 Interim 05 Feb 2009 Equity shares
08 Sep 2008 3.0 Final 10 Sep 2008 Equity shares
28 Jul 2008 40.0 Interim 29 Jul 2008 Equity shares
05 Feb 2008 4.0 Interim 06 Feb 2008 Equity shares
03 Aug 2007 2.0 Final 07 Aug 2007 Equity shares
24 Jan 2007 4.0 Interim 25 Jan 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
14 Feb 2005 0.0 Interim 15 Feb 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
13 Apr 2018 2.0 1.0 16 Apr 2018
25 Oct 2012 10.0 2.0 29 Oct 2012
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Feb 2024 1.0 Interim 2 20 Feb 2024 Equity shares
23 Nov 2023 1.0 Interim 1 23 Nov 2023 Equity shares
14 Sep 2023 2.6 Final 14 Sep 2023 Equity shares
24 Feb 2023 1.0 Interim 2 24 Feb 2023 Equity shares
14 Nov 2022 1.0 Interim 1 15 Nov 2022 Equity shares
14 Sep 2022 2.6 Final 16 Sep 2022 Equity shares
18 Feb 2022 1.0 Interim 2 21 Feb 2022 Equity shares
16 Nov 2021 1.0 Interim 1 17 Nov 2021 Equity shares
15 Sep 2021 2.6 Final 16 Sep 2021 Equity shares
17 Feb 2021 0.8 Interim 2 19 Feb 2021 Equity shares
19 Nov 2020 0.8 Interim 1 20 Nov 2020 Equity shares
18 Feb 2020 1.55 Interim 2 21 Feb 2020 Equity shares
15 Nov 2019 0.55 Interim 1 18 Nov 2019 Equity shares
17 Sep 2019 1.05 Final 19 Sep 2019 Equity shares
20 Feb 2019 0.55 Interim 2 21 Feb 2019 Equity shares
12 Nov 2018 0.55 Interim 1 13 Nov 2018 Equity shares
07 Sep 2018 0.85 Final 11 Sep 2018 Equity shares
22 Feb 2018 1.1 Interim 2 23 Feb 2018 Equity shares
16 Nov 2017 1.1 Interim 1 17 Nov 2017 Equity shares
13 Sep 2017 1.65 Final 14 Sep 2017 Equity shares
16 Feb 2017 1.1 Interim 2 17 Feb 2017 Equity shares
17 Nov 2016 1.1 Interim 1 18 Nov 2016 Equity shares
18 Mar 2016 2.65 Interim 2 21 Mar 2016 Equity shares
17 Feb 2016 1.2 Interim 19 Feb 2016 Equity shares
10 Sep 2015 2.4 Final 12 Sep 2015 Equity shares
13 Feb 2015 1.1 Interim 17 Feb 2015 Equity shares
17 Sep 2014 2.2 Final 19 Sep 2014 Equity shares
17 Feb 2014 1.0 Interim 19 Feb 2014 Equity shares
02 Aug 2013 2.0 Final 06 Aug 2013 Equity shares
21 Feb 2013 1.0 Interim 22 Feb 2013 Equity shares
20 Sep 2012 10.0 Final 24 Sep 2012 Equity shares
23 Feb 2012 5.0 Interim 24 Feb 2012 Equity shares
12 Sep 2011 10.0 Final 14 Sep 2011 Equity shares
21 Feb 2011 5.0 Interim 22 Feb 2011 Equity shares
13 Aug 2010 10.0 Final 17 Aug 2010 Equity shares
09 Feb 2010 5.0 Interim 10 Feb 2010 Equity shares
16 Sep 2009 12.0 Final 18 Sep 2009 Equity shares
04 Feb 2009 5.0 Interim 05 Feb 2009 Equity shares
08 Sep 2008 3.0 Final 10 Sep 2008 Equity shares
28 Jul 2008 40.0 Interim 29 Jul 2008 Equity shares
05 Feb 2008 4.0 Interim 06 Feb 2008 Equity shares
03 Aug 2007 2.0 Final 07 Aug 2007 Equity shares
24 Jan 2007 4.0 Interim 25 Jan 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
14 Feb 2005 0.0 Interim 15 Feb 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
13 Apr 2018 2.0 1.0 16 Apr 2018
25 Oct 2012 10.0 2.0 29 Oct 2012

AMRUTAJAN HEALTH LTD Share Price

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management.

Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon.

The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%.

Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company.

'Diakyur' for the treatment of Diabetes was introduced during 2000-2001.

The name of Company changed from 'Amrutanjan Limited' to 'Amrutanjan Health Care Limited' during the year 2007-08. During the year 2009-10, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division.

During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Siva's Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares.

The Company launched Amrutanjan Headache Faster Relaxation Roll-on 10ml SKU; launched Amrutanjan Faster Relaxation Balm(white) during the year 2014-15.

In FY 2016-17, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company.

Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 2016-17. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was re-launched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 2018-19. The flavour Alphonso, the King of Mangoes', was launched in 200 ml Ready- to- drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 2019-20. The Company re-launched its headache Pain balm in 2021-22. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, 'Amrutanjan Stop Pain Dental Gel' was launched for Oral Health Care in 2023. In FY 2024, it launched Pain cream and Electro Plus Lemon and Low-sugar variants.

Parent organization Amrutanjan Group
NSE symbol AMRUTANJAN
Founded 1936
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Amrutanjan Health Care Ltd?

Answer Field

The share price of Amrutanjan Health Care Ltd for NSE is ₹ 694.3 and for BSE is ₹ 699.9.

What is the Market Cap of Amrutanjan Health Care Ltd?

Answer Field

The market cap of Amrutanjan Health Care Ltd for NSE is ₹ 10,14.74 Cr. and for BSE is ₹ 10,22.92 Cr. as of now.

What is the 52 Week High and Low of Amrutanjan Health Care Ltd?

Answer Field

The 52 Week High and Low of Amrutanjan Health Care Ltd for NSE is ₹ 862.60 and ₹ 544.10 and for BSE is ₹ 861.40 and ₹ 548.05.

How to Buy Amrutanjan Health Care Ltd share?

Answer Field

You can trade in Amrutanjan Health Care Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Amrutanjan Health Care Ltd?

Answer Field

The 1 year returns on the stock has been -4.13%.

What is the Current Share Price of Amrutanjan Health Care Ltd?

Answer Field

Amrutanjan Health Care Ltd share price is for NSE ₹ 694.3 & for BSE ₹ 699.9 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Amrutanjan Health Care Ltd Share?

Answer Field

The market cap of Amrutanjan Health Care Ltd for NSE ₹ 10,14.74 & for BSE ₹ 10,22.92 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Amrutanjan Health Care Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Amrutanjan Health Care Ltd share is 39.81.

What is the PB ratio of Amrutanjan Health Care Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Amrutanjan Health Care Ltd share is 103.00.

How to Buy Amrutanjan Health Care Ltd Share?

Answer Field

You can trade in Amrutanjan Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Amrutanjan Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Amrutanjan Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Amrutanjan Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|